๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice

โœ Scribed by Klein, Karen A.; Reiter, Robert E.; Redula, James; Moradi, Hamid; Zhu, Xaio Lin; Brothman, Arthur R.; Lamb, Dolores J.; Marcelli, Marco; Belldegrun, Arie; Witte, Owen N.


Book ID
109928166
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
809 KB
Volume
3
Category
Article
ISSN
1078-8956

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Androgen receptor: A key molecule in the
โœ Mary-Ellen Taplin; Steven P. Balk ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB ๐Ÿ‘ 2 views

## Abstract Despite earlier detection and recent advances in surgery and radiation, prostate cancer is second only to lung cancer in male cancer deaths in the United States. Hormone therapy in the form of medical or surgical castration remains the mainstay of systemic treatment in prostate cancer.

Role of antioxidant systems in human and
โœ Suzuki, Yasutomo; Kondo, Yukihiro; Himeno, Seiichiro; Nemoto, Kaoru; Akimoto, Ma ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 228 KB ๐Ÿ‘ 2 views

## BACKGROUND. Most prostate cancer cells respond to initial hormonal therapy; however, some of them eventually acquire resistance to the hormonal therapy. Hormone-independent prostate cancer usually exhibits resistance to chemotherapy and radiotherapy. Antioxidant systems are known to be involved